News In Brief

Thursday, November 3, 2016
Immunotherapy, which uses the body’s own immune system to fight disease, is transforming the treatment of several types of cancers. Severe adverse effects can result from these groundbreaking cancer treatments, however, and when they do, it’s important to recognize and quickly address them, researchers write in the New England Journal of Medicine.
Tuesday, November 1, 2016
How to harness the immune system to improve the outcome of ovarian cancer patients was the focus of a presentation by Kunle Odunsi, MD, PhD, Deputy Director of Roswell Park Cancer Institute, at the 16th Biennial Meeting of the International Gynecologic Cancer Society in Lisbon, Portugal.
Friday, October 28, 2016
The first comprehensive study analyzing follow-up care among childhood cancer survivors concludes that fewer than than half of the adult survivors of childhood cancers — who remain at greater risk for chronic illnesses — receive adequate long-term follow-up care.
Tuesday, October 25, 2016
Kunle Odunsi, MD, PhD, FRCOG, Deputy Director of Roswell Park Cancer Institute, has been re-elected to the prestigious leadership position as Co-chair of the National Cancer Institute’s (NCI) Ovarian Task Force of the Gynecologic Cancer Steering Committee. He will serve for three years.
Monday, October 17, 2016
Low levels of vitamin D may be impacting survivors of childhood cancer and contributing to their long-term health issues following cancer treatment, say researchers at Roswell Park Cancer Institute in new research published in the International Journal of Cancer Therapy and Oncology.
Wednesday, October 12, 2016
Marc Ernstoff, MD, Chair of the Department of Medicine and Senior Vice President for Clinical Investigation at Roswell Park Cancer Institute, has co-authored the clinical practice guidelines for melanoma within a new edition of a global medical oncology training reference guide.
Friday, September 2, 2016
Scientists at Roswell Park Cancer Institute have developed a new approach to address health issues among Native Americans. The effort was led by Rodney Haring, PhD, MSW, Assistant Professor of Oncology in the Office of Cancer Health Disparities Research at Roswell Park.
Monday, August 22, 2016
Roswell Park Cancer Institute has once again been named to Becker’s Hospital Review’s 100 Hospitals and Health Systems with Great Oncology Programs, an annual list of centers that are national leaders in patient care, cancer outcomes and research.
Monday, August 15, 2016
Excessive inflammation contributes to a variety of diseases, including cancer. The class of molecules known as resolvins appears to modify disease progression by decreasing inflammation, offering a potential therapeutic option, according to a recent review article published in the World Journal of Clinical Cases and co-authored by Kazuaki Takabe, MD, PhD, FACS, Clinical Chief of Breast Surgery at Roswell Park Cancer Institute.
Thursday, August 11, 2016
Unlocking the power of patient data and connecting health care information to improve patient care are two topics that will be presented by information technology experts from Roswell Park Cancer Institute at the annual Allscripts Client Experience conference, August 9–11 in Las Vegas, Nev.
Monday, August 1, 2016
New insights on age-related diseases may hold the key to both delaying aging and, in the process, reducing the occurrence of diseases including cancer.
Friday, July 29, 2016
When it comes to sharing experiences caring for a child with cancer, parents often turn to social media as a way to connect with support. Those are the findings of new research led by Roswell Park Cancer Institute researchers and published online ahead of print by the journal Cancer Nursing.